News
- Author:
- Neil Osterweil
Publish date: March 7, 2024
Depression and anxiety are highly prevalent among patients with severe, chronic obstructive lung diseases, and require a multiprong treatment appro...
News
- Author:
- Neil Osterweil
Publish date: March 4, 2024
Stricter standards for acceptable levels of fine particulate matter in air promise to improve pulmonary health and reduce pollution-related mortali...
News
- Author:
- Neil Osterweil
Publish date: March 4, 2024
Depression and anxiety are highly prevalent among patients with severe, chronic obstructive lung diseases, and require a multi-prong treatment appr...
News
- Author:
- Neil Osterweil
Publish date: February 15, 2024
In a small study, patients successfully treated for early, localized cutaneous melanoma expressed anxieties about recurrence, life changes, and dea...
News
- Author:
- Neil Osterweil
Publish date: February 12, 2024
The impact on psoriasis of higher doses of JNJ-77242113 at week 16 "was similar in magnitude to the responses seen with several of the injectable b...
News
- Author:
- Neil Osterweil
Publish date: February 9, 2024
Rates of significant disease reactivation were similar more than 1 year after randomization for patients assigned to mycophenolate mofetil (MMF) wi...
News
- Author:
- Neil Osterweil
Publish date: February 7, 2024
Omega-3 fatty acid supplements prevented autoimmune diseases for 2 years after cessation, but vitamin D’s effects tapered off, suggesting that cont...
News
- Author:
- Neil Osterweil
Publish date: January 31, 2024
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
News
- Author:
- Neil Osterweil
Publish date: January 31, 2024
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA repair...
News
- Author:
- Neil Osterweil
Publish date: January 26, 2024
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
News
- Author:
- Neil Osterweil
Publish date: December 15, 2023
New study finds a top performer among “preferred” treatment combos for patients with multiple myeloma who can’t get stem cell transplants.
News
- Author:
- Neil Osterweil
Publish date: December 12, 2023
Phase-3 analysis shows that a drug combo for chronic lymphocytic leukemia yielded better outcomes than chemoimmunotherapy.
News
- Author:
- Neil Osterweil
Publish date: December 12, 2023
New FDA data analysis shows CAR T-cell and other anti-BCMA treatments for multiple myeloma are linked to considerable risks for side effects.
News
- Author:
- Neil Osterweil
Publish date: December 11, 2023
New research on a just-approved gene therapy for sickle cell disease shows the efficacy of a single infusion of lovo-cel.
News
- Author:
- Neil Osterweil
Publish date: November 17, 2023
“I’m encouraged by the results with low-dose aspirin, and I think that, given the risk profile, using a lower dose is preferable.”
